Triclabendazole Market: Introduction
According to the report, the global triclabendazole market was valued at US$ 412 Mn in 2020 and is projected to expand at a CAGR of 4.1% from 2021 to 2031. Triclabendazole is a well-known anthelmintic flukicide that belongs to the benzimidazole chemical family. It is widely used on sheep, goats, and cattle, primarily as drenches and seldom in tablets, boluses, or other forms. Only triclabendazole is effective against the very early phases of liver fluke infection, from two weeks after infection to adulthood. Triclabendazole is one of the primary controlling measures for eradicating trematode Fasciola hepatica in livestock. Hence, the use of triclabendazole for animals is anticipated to increase during the forecast period, which is expected to boost the growth of the global market.
Increase in Incidence of Faciolas Hepatica (Liver Fluke)
Fasciola hepatica, also known as the common liver fluke, occurs in many areas of the world and is usually caused by F. hepatica. In general, fascioliasis is more common and widespread in animals than in people. In the U.K., fluke prevalence in adult dairy cattle has been reported to be 48% to 76%. Prevalence of F. hepatica has increased in the past few years, and fasciolosis has been reported in new areas, thought to be due to wetter summers and warmer winters.
Get a sample of the report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=82892
Factors such as rise in demand for improved nutrition, particularly animal protein, and increase in focus on food safety are likely to boost the demand for triclabendazole medicine over the next few years. The demand for milk and milk products has increased in the past few years, which, in turn, is projected to fuel the growth of the global triclabendazole market during the forecast period. Hence, increase in incidence of Faciolas hepatica or liver fluke is anticipated to propel the global market.
Oral Suspension Segment to Lead Triclabendazole Market
In terms of dosage form, the global triclabendazole market has been bifurcated into liquid transfer tablet and oral suspension. The oral suspension segment dominated the market, accounting for 89.2% share in 2020. Oral suspension formulations containing triclabendazole are more successful in treating liver fluke, as it provides a suitable volume of oral formulation and proper dosage can be administered.
Cattle Segment to Dominate Global Triclabendazole Market
Based on animal type, the global triclabendazole market has been classified into cattle, sheep, goat, and others. Liver fluke is likely to cost the livestock sector around US$ 2.2 Bn per year globally, as it deteriorates cattle health. Hence, use of triclabendazole in treating Fasciola hepatica in cattle is expected to drive the segment during the forecast period. Liver fluke can infect all grazing animals, but primarily affects sheep and cattle. It is most pathogenic in sheep, and acts as the main definitive host. Losses caused due to it are estimated at US$ 4 to US$ 5 per infected sheep. These factors are likely to propel the segment during the forecast period.
Request for Analysis of COVID-19 Impact onTriclabendazole Market @ https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=82892
Veterinary Hospitals to be Key Distribution Channel
In terms of distribution channel, the global triclabendazole market has been classified into veterinary hospitals, veterinary clinics, pharmacies & drug stores, and others. The veterinary hospitals segment dominated the market, accounting for 26.4% share in 2020. The trend is projected to continue during the forecast period. Veterinary hospitals have systems with maximum compatibility for the animals and consist of more veterinary professionals. This is likely to drive the segment during the forecast period.
North America to Lead Global Triclabendazole Market
In terms of region, the global triclabendazole market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global triclabendazole market in 2020, accounting for 30.9% share, owing to large livestock population, increase in spending on preventive health care, and rise in number of veterinary clinics in the U.S.
Europe held significant share of the global market in 2020, due to presence of several key players in animal health. It is likely to be an attractive market during the forecast period. This can be attributed to large livestock population and rise in prevalence of liver fluke in grazing animals.
Make an Enquiry before Buying @ https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=82892
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update – https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
USA – Canada Toll Free: 866-552-3453
Email: [email protected]